• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Characteristics, Comorbidities, and Data Gaps for Coronavirus Disease Deaths, Tennessee, USA

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2021 Oct;27(10):2521-2528.
doi: 10.3201/eid2710.211070.
Characteristics, Comorbidities, and Data Gaps for Coronavirus Disease Deaths, Tennessee, USA

John James Parker, Rany Octaria, Miranda D Smith, Samantha J Chao, Mary Beth Davis, Celia Goodson, Jon Warkentin, Denise Werner, Mary-Margaret A Fill

Abstract

As of March 2021, coronavirus disease (COVID-19) had led to >500,000 deaths in the United States, and the state of Tennessee had the fifth highest number of cases per capita. We reviewed the Tennessee Department of Health COVID-19 surveillance and chart-abstraction data during March 15‒August 15, 2020. Patients who died from COVID-19 were more likely to be older, male, and Black and to have underlying conditions (hereafter comorbidities) than case-patients who survived. We found 30.4% of surviving case-patients and 20.3% of deceased patients had no comorbidity information recorded. Chart-abstraction captured a higher proportion of deceased case-patients with >1 comorbidity (96.3%) compared with standard surveillance deaths (79.0%). Chart-abstraction detected higher rates of each comorbidity except for diabetes, which had similar rates among standard surveillance and chart-abstraction. Investing in public health data collection infrastructure will be beneficial for the COVID-19 pandemic and future disease outbreaks.

Keywords: Black patients; COVID-19; Hispanic patients; SARS-CoV-2; Tennessee; United States; White patients; comorbidities; coronavirus disease; coronaviruses; epidemiology; ethnic groups; mortality rates; population characteristics; public health surveillance; respiratory infections; severe acute respiratory syndrome coronavirus 2; underlying conditions; viruses; zoonoses.
 
Back
Top Bottom